698 filings
Page 9 of 35
8-K
ociob1j26d6wcn
30 Mar 22
KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
4:36pm
8-K
vr9jc95oweq834e
21 Mar 22
KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
8:49am
8-K
axu18hbwr pdcj
16 Mar 22
KemPharm team provided development and regulatory services to Corium pursuant to a master development services agreement
8:32am
8-K
xvxoxk eojn
22 Feb 22
Regulation FD Disclosure
9:09am
SC 13G
79q wybt5oo7n0qtu7
4 Feb 22
KEMPHARM / BlackRock ownership change
4:12pm
4
di6nirosgrseq4nf57
3 Feb 22
KEMPHARM / Timothy J. Sangiovanni ownership change
5:17pm
4
6bl6wgvagdk7xbhwyckb
3 Feb 22
KEMPHARM / Sven Guenther ownership change
5:17pm
4
jpgfek75
3 Feb 22
KEMPHARM / R. LaDuane Clifton ownership change
5:15pm
4
uuwi85l
3 Feb 22
KEMPHARM / Richard W Pascoe ownership change
5:14pm
4
c0n57p68z
3 Feb 22
KEMPHARM / Travis C Mickle ownership change
5:12pm
424B3
9uxl0f06h j5l
2 Feb 22
Prospectus supplement
4:16pm
EFFECT
2cr4 s3pi02h
2 Feb 22
Notice of effectiveness
12:15am
POS EX
uy0i8ry580x0amq5
28 Jan 22
Additional exhibits for listing
6:15am
POS AM
rjvvzr56awg14l1h12n
25 Jan 22
Prospectus update (post-effective amendment)
4:56pm
424B3
ul7dm7r1yqlbzhkg
19 Jan 22
Prospectus supplement
9:43pm
8-K
fzcqpc2do0exh6
19 Jan 22
KemPharm Issues Letter to Shareholders Detailing Strategic Focus on CNS/Rare Disease Indications and Updated Clinical Development Strategy
4:27pm
SC 13G/A
c5z7ybovhzyq2kvjcr5q
12 Jan 22
KEMPHARM / Braun Samuel J ownership change
4:03pm
SC 13G/A
q6mjcv
11 Jan 22
KEMPHARM / Empery Asset Management ownership change
10:30am
424B3
75pp8v
20 Dec 21
Prospectus supplement
7:44am
8-K
v6991c8yp 7r
20 Dec 21
KemPharm, Inc. Announces Authorization of $50 Million Share Repurchase Program
7:43am